Oracle’s Unified Cloud Platform Promises to Shorten Clinical Trials

June 19, 2017

Oracle’s Clinical One Platform will enable pharmaceutical companies to manage every trial function from randomizing patient participants and collecting and analyzing data to tracking budgets and ensuring trial safety from a single user interface.

Spotlight

Drug Discovery and Development Centre (H3D), University of Cape Town

H3D is Africa’s first integrated drug discovery and development centre. The Centre is an accredited University of Cape Town research centre within the Faculty of Science but with strong affiliations with the Faculty of Health Sciences and specifically the Division of Pharmacology and the Institute for Infectious Diseases and Molecular Medicine (IDM). H3D operates within UCT’s world-class translational medicine research environment.

OTHER WHITEPAPERS
news image

Reimagining the pharma landscape with design thinking

whitePaper | July 29, 2021

As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.

Read More
news image

Why Deck 7

whitePaper | January 1, 2020

With over 2,800 campaigns each year delivered through a team of 300+ digital, data, and technology specialists, Deck 7 is a first resource for B2B demand generation services for marketers worldwide. Clients leverage Deck 7’s multichannel content marketing services and Media 7’s network of 30+ online publications for content syndication to engage over 95 million buyers across 16 industries and 120+ countries.

Read More
news image

Characterization of Protein Aggregates and Other Particles in Biopharmaceuticals

whitePaper | July 8, 2022

Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production1–3. These particles must be monitored to satisfy.

Read More
news image

BUILDING A TOMORROW-READY LAB

whitePaper | September 8, 2022

Charles Darwin famously said on survival, "It is not the strongest of the species that survives, nor the most intelligent; it is the one most adaptable to change." Resilience has become an essential message in today's post-covid, next-normal world.

Read More
news image

Measuring the COVID Effect on Clinical Trials

whitePaper | June 27, 2022

As the world begins its transition into a postpandemic existence, it becomes possible to look back on the past two years and begin to quantify the effects that COVID-19 has brought.

Read More
news image

Coronavirus (COVID-19) and Its Effect on Pharmaceutical Marketing and Sales

whitePaper | March 16, 2020

With the rapid onset of coronavirus in the United States, many pharma companies are being forced to prepare for a scenario in which their reps cannot visit providers and patients are limited in their ability to visit their healthcare professionals (HCP). The CDC has gone as far as recommending the use of telemedicine and patient portals as primary channels for HCPs and patients to interact.

Read More

Spotlight

Drug Discovery and Development Centre (H3D), University of Cape Town

H3D is Africa’s first integrated drug discovery and development centre. The Centre is an accredited University of Cape Town research centre within the Faculty of Science but with strong affiliations with the Faculty of Health Sciences and specifically the Division of Pharmacology and the Institute for Infectious Diseases and Molecular Medicine (IDM). H3D operates within UCT’s world-class translational medicine research environment.

Events